| Thursday, 22 October 2026 | ||
| 17:00 - 20:30 | 10th ESE and Endobridge Early Career session (By invitation only) | |
| DAY 1 - Friday, 23 October 2026 | ||
| 08:40 - 09:00 MAIN HALL |
Welcome and Introduction to EndoBridge 2026 | |
| 09:00 - 11:00 MAIN HALL |
||
| 09:00 - 09:30 | How to treat nonfunctioning pituitary adenomas? - Aj van der Lely | |
| 09:30 - 10:00 | Navigating non-classical lesions of the pituitary - Vera Popovic | |
| 10:00 - 10:30 | An update on SRLs, new compounds and indications - Nienke Biermasz | |
| 10:30 - 11:00 | Managing hypercortisolism in 2026 – a practical approach - Felix Beuschlein | |
| 11:00 - 11:20 | Coffee Break | |
| 11:20 - 12:50 | Interactive Case Discussion Sessions | |
| HALL A | PITUITARY | |
| HALL B | ADRENAL | |
| HALL C | MALE REPRODUCTIVE ENDOCRINOGY | |
| HALL D | NEUROENDOCRINE TUMORS | |
| 12:50 - 14:00 | Lunch | |
| 14:00 - 15:30 | Interactive Case Discussion Sessions | |
| HALL A | PITUITARY | |
| HALL B | ADRENAL | |
| HALL C | FEMALE REPRODUCTIVE ENDOCRINOLOGY | |
| 15:30 - 15:50 | Coffee Break | |
| 15:50 - 17:50 MAIN HALL |
||
| 15:50 - 16:20 | Testosterone, sperm, and time: Rethinking male hypogonadism across the reproductive lifespan - Dimitrios Goulis | |
| 16:20 - 16:50 | The everyday menopause clinic: A stepwise guide to hormonal and alternative treatments - Eleni Armeni | |
| 16:50 - 17:20 | Adrenal insufficiency: The roadmap to precision therapy - Wiebke Arlt | |
| 17:20 - 17:50 | Adrenal masses: When to be concerned - benignity, malignancy & more - Gary Hammer | |
| DAY 2 - Saturday, 24 October 2026 | ||
| 09:00 - 11:00 MAIN HALL |
 |
|
| 09:00 - 09:30 | Fat distribution as a determinant of diabetes: Clinical and metabolic implications – Robert Wagner | |
| 09:30 - 10:00 | Diabetic microvascular disease: New insights into non-classical target organs – Didac Mauricio | |
| 10:00 - 10:30 | Diabetes in women: What changes across the life course? – Johanna Brix | |
| 10:30 - 11:00 | Automated diabetes care: Current standards and future directions – Alice Cheng | |
| 11:00 - 11:20 | Coffee Break | |
| 11:20 - 12:50 | Interactive Case Discussion Sessions | |
| HALL A | DIABETES | |
| HALL B | THYROID | |
| HALL C | BONE AND CALCIUM | |
| HALL D | OBESITY, METABOLISM AND NUTRITION | |
| 12:50 - 14:00 | Lunch | |
| 14:00 - 15:30 | Interactive Case Discussion Sessions | |
| HALL A | DIABETES | |
| HALL B | THYROID | |
| HALL C | BONE AND CALCIUM | |
| HALL D | OBESITY, METABOLISM AND NUTRITION | |
| 15:30 - 15:50 | Coffee Break | |
| 15:50 - 17:50 MAIN HALL |
||
| 15:50 - 16:20 | Managing thyroid emergencies – Peter Taylor | |
| 16:20 - 16:50 | New risk stratification tools for thyroid nodules – Trevor Angell | |
| 16:50 - 17:20 | Highlights from the 2025 ATA guidelines on differentiated thyroid cancer – Julie-Ann Sosa | |
| 17:20 - 17:50 | Managing mild hypothyroidism and thyroid autoimmunity in pregnancy – Kristien Boelaert | |
| DAY 3 - Sunday, 25 October 2026 | ||
| 09:00 - 11:00 MAIN HALL |
||
| 09:00 - 09:30 | Optimizing bone health in patients with cancer – Joy Y. Wu | |
| 09:30 - 10:00 | Osteoporosis in the elderly – Maria Yavropoulou | |
| 10:00 - 10:30 | Insights to the 2025 ESE revision on management of chronic hypoparathyroidism in adults – from guideline to the clinic – Jens Bollerslev | |
| 10:30 - 11:00 | Bone metabolism in parathyroid disorders with a focus on long-term outcomes and fracture risk – Anda Mihaela Naciu | |
| 11:00 - 11:20 | Coffee Break | |
| 11:20 - 13:20 MAIN HALL |
 |
|
| 11:20 - 11:50 | Neurobiology of obesity: Regulation of appetite and metabolism – Gema Frühbeck | |
| 11:50 - 12:20 | The pharmacological treatment of obesity and its complications: EASO framework for the obesity management and EASL-EASO guidelines for MASLD – Andreea Ciudin |
|
| 12:20 - 12:50 | Nutritional, functional and psychological considerations for incretin-based therapies in adults – Laurence Dobbie | |
| 12:50 - 13:20 | The next frontier in lipid management: From emerging targets to personalized care – Lale Tokgözoğlu | |
| 13:20 - 13:30 | Closing comments and adjourn | |